 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/19/2024 |
$26.06 |
$26.88 |
$25.57 |
$25.98 |
626.30K | | 04/22/2024 |
$26.17 |
$27.74 |
$25.96 |
$27.06 |
328.00K | | 04/23/2024 |
$27.03 |
$28.80 |
$27.03 |
$27.93 |
314.10K | | 04/24/2024 |
$28.20 |
$28.38 |
$26.59 |
$26.98 |
266.40K | | 04/25/2024 |
$26.09 |
$26.80 |
$25.41 |
$26.17 |
526.90K |
|
|
| Arcturus Therapeutics Holdings is a clinical -stage messenger RNA medicines and vaccine company focused on the development of infectious disease vaccines and other opportunities within liver and respiratory rare diseases. Co.'s initial COVID-19 vaccine candidate, ARCT-021, was designed to promote immune responses to the spike protein of the Severe Acute Respiratory Syndrome-2 virus, which is the part of the virus that allows infection to occur. The LUNAR-OTC development program addresses ornithine transcarbamylase (OTC) deficiency, a genetic disease caused by mutations in the OTC gene that lead to dysfunctional or deficient OTC. The LUNAR-CF program addresses cystic fibrosis lung disease. | |
|
Arcturus Therapeutics Holdings (ARCT) has the following price history information. Looking back at ARCT historical stock prices for the last five trading days, on April 19, 2024, ARCT opened at $26.06, traded as high as $26.88 and as low as $25.57, and closed at $25.98. Trading volume was a total of 626.30K shares. On April 22, 2024, ARCT opened at $26.17, traded as high as $27.74 and as low as $25.96, and closed at $27.06. Trading volume was a total of 328.00K shares. On April 23, 2024, ARCT opened at $27.03, traded as high as $28.80 and as low as $27.03, and closed at $27.93. Trading volume was a total of 314.10K shares. On April 24, 2024, ARCT opened at $28.20, traded as high as $28.38 and as low as $26.59, and closed at $26.98. Trading volume was a total of 266.40K shares. On April 25, 2024, ARCT opened at $26.09, traded as high as $26.80 and as low as $25.41, and closed at $26.17. Trading volume was a total of 526.90K shares.
ARCT Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Arcturus Therapeutics Holdings shares, starting with a $10,000 purchase of ARCT, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/28/2014 |
|
| End date: |
04/25/2024 |
|
| Start price/share: |
$122.50 |
|
| End price/share: |
$26.17 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-78.64% |
|
| Average Annual Total Return: |
-14.30% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$2,137.02 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/19/2024 | $25.98 | | 04/22/2024 | $27.06 | | 04/23/2024 | $27.93 | | 04/24/2024 | $26.98 | | 04/25/2024 | $26.17 |
|
|
